Probiotix Health (AQSE:PBX) Change In Receivables : £0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health Change In Receivables?

Probiotix Health's change in receivables for the quarter that ended in Jun. 2023 was £0.40 Mil. It means Probiotix Health's Accounts Receivable declined by £0.40 Mil from Dec. 2022 to Jun. 2023 .

Probiotix Health's change in receivables for the fiscal year that ended in Dec. 2022 was £-0.44 Mil. It means Probiotix Health's Accounts Receivable increased by £0.44 Mil from Dec. 2020 to Dec. 2022 .

Probiotix Health's Accounts Receivable for the quarter that ended in Jun. 2023 was £0.10 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Probiotix Health's Days Sales Outstanding for the six months ended in Jun. 2023 was 33.39.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Probiotix Health's liquidation value for the six months ended in Jun. 2023 was £1.39 Mil.

Probiotix Health Change In Receivables Historical Data

The historical data trend for Probiotix Health's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health Change In Receivables Chart

Probiotix Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec22

Change In Receivables

-0.18

-0.10

-0.11

-0.44

Probiotix Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Change In Receivables	Get a 7-Day Free Trial			-0.31	-0.15	-0.05	-0.39	0.40

Probiotix Health Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

Probiotix Health (AQSE:PBX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Probiotix Health's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.101	/	0.552	*	91
=	33.39

2. In Ben Graham's calculation of liquidation value, Probiotix Health's accounts receivable are only considered to be worth 75% of book value:

Probiotix Health's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.948	-	0.67	+	0.75 * 0.101	+	0.5 * 0.077
=	1.39

Probiotix Health Change In Receivables Related Terms

Thank you for viewing the detailed overview of Probiotix Health's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Probiotix Health (AQSE:PBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

X90:Germany

Address

Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB

Website

https://www.probiotixhealth-ir.com

Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines